Streetbeat News

Revenues

EXEL

Exelixis (NASDAQ:EXEL) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 7% to $30.25. Exelixis has shown strong financial performance with significant revenue growth and high net margins.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:00 pm

ELV

Analysts have provided mixed evaluations for Elevance Health (NYSE:ELV) over the past quarter, with a trend towards lowering price targets. The average 12-month price target is now $559.91, down 7.03% from the previous $602.27. Despite some positive financial metrics, such as ROE and ROA, Elevance Health faces challenges with net margin and revenue growth compared to industry peers.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:00 pm

FITB

Fifth Third Bancorp (NASDAQ:FITB) has received mixed analyst ratings over the past three months, with a recent upward trend in price targets. Analysts have set a 12-month average price target of $49.0, reflecting an 11.36% increase from the previous target. Despite challenges in revenue growth, the company maintains strong net margins and return on equity.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:00 pm

ALK

Analysts have mixed ratings for Alaska Air Group (NYSE:ALK), with a recent increase in the average 12-month price target to $51.43. The company shows strong financial performance with a 2.08% revenue growth, a net margin of 7.59%, and a debt-to-equity ratio of 0.92.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:01 pm

STGW

Stagwell (NASDAQ:STGW) has been analyzed by 5 analysts, showing a range of bullish to bearish perspectives. The average 12-month price target is $8.0, with a slight decrease in sentiment. Analysts maintain 'Buy' ratings, but some have lowered price targets. Stagwell shows positive revenue growth but faces challenges in debt management and return on equity.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:01 pm

UTHR

In the past three months, 7 analysts have evaluated United Therapeutics (NASDAQ:UTHR), with a majority expressing bullish sentiments. Analysts have set a 12-month average price target of $409.57, reflecting an 18.57% increase from the previous target. The company has shown strong financial performance with a notable net margin and ROE, despite lagging revenue growth compared to peers.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:01 pm

RVLV

In the past three months, 10 analysts have rated Revolve Group (NYSE:RVLV), with a mix of bullish and bearish perspectives. The average 12-month price target has increased by 16.19% to $24.4. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Revolve Group, an e-commerce retailer, has shown strong financial performance with notable revenue growth, net margin, ROE, and ROA, despite being smaller in market capitalization compared to peers.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

VSCO

Victoria's Secret (NYSE:VSCO) has been analyzed by 17 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has increased by 11.9% to $24.82. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Despite challenges like a -0.7% revenue decline and high debt-to-equity ratio, the company shows strong ROE.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

KEY

Analysts have provided mixed evaluations for KeyCorp (NYSE:KEY) over the past three months, with a range of ratings from bullish to bearish. The average 12-month price target has increased to $18.46, reflecting a 5.97% rise. Despite challenges in revenue growth and returns, KeyCorp maintains a strong net margin and balanced debt management.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

MFG

MUFG

SMFG

Japanese banks' shares are trading lower following the release of data showing a slowdown in Japan's September core CPI.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 7:00 pm